The DOI matches its Crossref record.
Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study
Abstract
This report examines prospectively, in the Framingham cohort, the relation of diabetes and impaired glucose tolerance to each of the cardiovascular sequelae, taking into account age, sex, and associated cardiovascular risk factors. The incidence of cardiovascular disease, as well as the levels of cardiovascular risk factors, were found to be higher in diabetic than in nondiabetic men and women. The relative impact of diabetes on coronary heart disease, peripheral vascular disease, or stroke incidence was the same in men and women, but for cardiovascular mortality and cardiac failure the impact is greater for women. Present evidence suggests that alleviation of associated cardiovascular risk factors is the most promising course in reducing cardiovascular sequelae in diabetic patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Diabetic patients are at high risk of cardiovascular events, particularly of coronary heart disease by about 3-fold [67,68].”
From Metformin: An Old But Still the Best Treatment for Type 2 Diabetes (2013) · cites this paper as [67]
In the citing paper
“T2DM is associated with a two-fold higher risk of CAD and ischaemic stroke”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [140]
In the citing paper
“and a two-to four-fold higher CAD-and stroke-related mortality.139 -141”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [140]
Citations
Cited by
Sorted by citations
Items 801–900 of 999
Screening asymptomatic patients with type 2 diabetes: The debates persist
Beller, G., & Bourque, J. M. (2015) · Journal of Nuclear Cardiology · doi:10.1007/s12350-015-0283-4 · Cited by 5
“Furthermore, these data showed that diabetes was associated with a 2 to 4 fold increased prevalence of CAD, and an increased risk of dying from CAD, compared to nondiabetic patients.(4,5) Other data supported the notion that patients with diabetes without a prior myocardial infarction (MI) had the same risk of coronar…”
ResultNutritional Considerations for Older Adults With Type 2 Diabetes
Josse, A. R., Panahi, S., Esfahani, A., Leiter, L. A., Jenkins, D. J. A., & Kendall, C. W. C. (2008) · Journal of Nutrition for the Elderly · doi:10.1080/01639360802265905 · Cited by 5
“This disease is associated with a number of serious microvascular and macrovascular complications over the longer term, including the development of retinopathy, with possible loss of vision; nephropathy, with possible eventual kidney failure; neuropathy with possible foot ulcers and amputations, and perhaps most impo…”
BackgroundDiabetic dyslipidaemia: effective management reduces cardiovascular risk.
Leiter, L. A. (2005) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2005.02.007 · Cited by 6
The use of metoprolol CR/XL in the treatment of patients with diabetes and chronic heart failure
Freitas, O. D., Lenz, O., Fornoni, A., & Materson, B. J. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.2.139 · Cited by 5
“All are known risk factors for the development of CHF (Kannel and McGee 1979; Almdal et al 2004).”
BackgroundNew Concepts for Treatment of Non-Insulin-Dependent Diabetes Mellitus
Larkins, R. G. (1997) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(97)00037-4 · Cited by 5
Dussol, B., & Berland, Y. (2006) · Néphrologie & Thérapeutique · doi:10.1016/j.nephro.2006.01.004 · Cited by 5
Alonso, V. B., Ruíz, R. C., & Guzmán, G. (2002) · Hipertensión y Riesgo Vascular · doi:10.1016/s1889-1837(02)71218-x · Cited by 5
Peripheral arterial disease and diabetes mellitus.
Coce, F., Metelko, Ž., Jaksic, B. S., et al. (2008) · Diabetologia Croatica · Cited by 5
Prevalence of diabetes in patients with myocardial infarction: a study in a tertiary care centre
Mohanty, L., Sahoo, D., Meher, D., & Sahoo, P. (2016) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20163186 · Cited by 5
Aso, Y. (2006) · Future Lipidology · doi:10.2217/17460875.1.4.429 · Cited by 5
“Patients with Type 2 diabetes have a high incidence of atherosclerotic cardiovascular disease (CVD), leading to increased morbidity and mortality due to coronary artery disease (CAD), stroke and peripheral vascular disease [1,2].”
BackgroundCoronary risk factors in post‐menopausal type 2 patients: A case for oestrogen replacement therapy
Ismail, A., & Gill, G. (1999) · Practical Diabetes · doi:10.1002/pdi.1960160505 · Cited by 5
Schuster, H. (2005) · European Heart Journal Supplements · doi:10.1093/eurheartj/sui004 · Cited by 5
Role of capillary ketone testing in the diagnosis and monitoring of diabetic ketoacidosis
Khalid, L., Aamir, A., Livingston, M. A., et al. (2017) · International Journal of Clinical Practice · doi:10.1111/ijcp.13028 · Cited by 4
H-FABP: A beacon of hope for prediabetic heart disease
Ramesh, P., Chauhan, A., Goyal, P., & Singh, A. (2020) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_296_20 · Cited by 4
“Centers for Disease Control and Prevention, and the American Heart Association for the assessment of risk for cardiovascular disease in adults.[8] Classification for Cardiovascular Disease Risk Conventional and SI Units (mg/L) is as follows: Low <1 Average 1–3 High 3–10 In determinant >10”
BackgroundAspirin in primary prevention of cardiovascular disease in diabetes
Papazafiropoulou, A. K., Melidonis, A. J., & Antonopoulos, S. (2021) · Archives of Medical Science - Atherosclerotic Diseases · doi:10.5114/amsad.2021.105596 · Cited by 5
“The increased risk of CVD in patients with DM has been known since the 1970s when the Rochester Epidemiologic Project and the Framingham Heart Study showed for the first time that people with DM are at increased risk for myocardial infarction (MI), stroke, and peripheral artery disease (PAD) compared to people without…”
BackgroundSharrack, N., Knott, K. D., Gulsin, G. S., Kotecha, T., Brown, L., Yeo, J. L., Porcari, A., Adam, R. D., Thirunavukarasu, S., Chowdhary, A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-77280-2 · Cited by 5
Is the Relationship Between Cardiovascular Disease and Alzheimer’s Disease Genetic? A Scoping Review
Moore, A. K., & Ritchie, M. D. (2024) · Genes · doi:10.3390/genes15121509 · Cited by 5
Hanzal, D., & Ducharme, A. (2006) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(06)70976-x · Cited by 4
Managing Cardiovascular Complications in Diabetes
Betteridge, J. D., & Nicholls, S. J. (2014) · Wiley eBooks · doi:10.1002/9781118337967 · Cited by 5
Inaku, K. O., Ogunkeye, O. O., Abbiyesuku, F., Chuhwak, E. K., Isichei, C. O., Imoh, L. C., Amadu, N., & Abu, A. O. (2017) · BMC Clinical Pathology · doi:10.1186/s12907-017-0065-9 · Cited by 4
“Improving glycaemic control has been shown to have a favourable effect on lipid and lipoprotein concentrations in type 2 diabetes [35, 36].”
BackgroundBandyopadhyay, D., Devanabanda, A. R., Tummala, R., Chakraborty, S., Hajra, A., Amgai, B., Akhtar, T., Jain, V., & Ghosh, R. K. (2019) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2019.100384 · Cited by 4
“The incidence of CAD is known to be as high as 50% in diabetic patients [1,2].”
BackgroundSocial Support and Self- Care Behaviour among Heart Failure Patients
Ainuddin, H. A., Talib, S. S., Abidin, M. Z. Z., & Katiman, D. (2019) · Environment-Behaviour Proceedings Journal · doi:10.21834/e-bpj.v4i12.1906 · Cited by 4
“Some of the common risk factors of heart disease include hypertension, diabetes, high cholesterol level, and smoking (Gordon & Kannel, 1982; Kannel & McGee, 1979; Gordon et al., 1977).”
BackgroundSilverman, A., Huang, C.-C. J., Russell, M., et al. (2009) · Digital Scholarship - UNLV (University of Nevada Reno) · Cited by 4
Apoptotic cell death in heart failure associated with diabetes
Bhuvaneshwari, P., & Riswana, N. (2019) · International Journal of Clinicopathological Correlation · doi:10.4103/ijcpc.ijcpc_1_19 · Cited by 4
“[7] In the Framingham cohort, men and women with diabetes had higher blood pressures and were more obese than nondiabetics; women with diabetes had, in addition, higher low‐density lipoprotein‐cholesterol values; high‐density lipoprotein‐cholesterol values were consistently lower in those with DM than in those without…”
BackgroundNIKOLOV, A. G., Tzekova, M., & Blazhev, A. B. (2019) · Folia Medica · doi:10.2478/folmed-2018-0072 · Cited by 4
Popović‐Pejičić, S., Todorovic-Djilas, L., & Pantelinac, P. (2006) · Medicinski pregled · doi:10.2298/mpns0604118p · Cited by 4
Vaidya, D. M., Kelemen, M. D., Bittner, V., Tardif, J., Thompson, P. D., & Ouyang, P. (2007) · Journal of Women s Health · doi:10.1089/jwh.2006.0107 · Cited by 4
Lammertyn, L., Schutte, R., Schutte, A. E., et al. (2011) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2010.531842 · Cited by 4
“These raised glucose levels seem to impact women more than men (10), and are considered to essentially negate some of the protective effects of the female gender against cardiovascular disease (11).”
BackgroundVascular disease and survival in patients with type 2 diabetes and nephropathy
Joss, N., Paterson, K., Deighan, C., Simpson, K., & Boulton-Jones, J. (2002) · The British Journal of Diabetes · doi:10.1177/14746514020020021201 · Cited by 8
The Evaluation of Cardiac and Peripheral Arterial Disease in Patients with Diabetes Mellitus
Shen, R., Wiegers, S. E., & Glaser, R. (2007) · Endocrine Research · doi:10.1080/07435800701743869 · Cited by 4
Yoshida, A., Jinnouchi, H., Sugiyama, S., Hirose, J., Segata, T., Furuta, K., Katahira, K., Kajiwara, K., Hieshima, K., Jinnouchi, T., et al. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.04.013 · Cited by 4
Kakorin, S. V., Iskandaryan, R. A., & Mkrtumyan, A. M. (2016) · Diabetes Mellitus · doi:10.14341/dm200412-6 · Cited by 4
Epigenetic role of micrornas in diabetic cardiomyopathy
Khullar, M., Raut, S. K., & Kumar, A. (2016) · Journal of the Practice of Cardiovascular Sciences · doi:10.4103/2395-5414.191519 · Cited by 4
Cerebral and peripheral vascular disease (with special emphasis on the diabetic foot)
Standl, E., & Stiegler, H. (2011) · De Gruyter eBooks · doi:10.1515/9783110872699.169 · Cited by 4
Diabetes Care in Older Adults: Current Issues in Management and Research
Anderson, L. A., & Halter, J. B. (1990) · Annual Review of Gerontology and Geriatrics · doi:10.1007/978-3-662-40455-3_2 · Cited by 4
Importance of Routine Measurement of HDL with Total Cholesterol in Diabetic Patients
Feher, M. D., Stevens, J., Lant, A. F., et al. (1992) · Journal of the Royal Society of Medicine · doi:10.1177/014107689208500104 · Cited by 4
Clinical Features and Diagnosis of Macrovascular Disease
Hile, C. N., Kansal, N., Hamdan, A. D., et al. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-075-1_8 · Cited by 4
Renal insufficiency, mortality and myocardial infarction
Holzmann, M. J. (2008) · Figshare · Cited by 4
Diabetes mellitus and risk of cardiovascular disease in women
Solomon, C. G. (1996) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-199601000-00007 · Cited by 4
Lambert, A., Hunt, M. A., Day, A., et al. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00687.x · Cited by 4
Should all diabetic patients receive statins?
Garcia, P. J., & Spellman, C. (2006) · Current Atherosclerosis Reports · doi:10.1007/s11883-006-0059-z · Cited by 4
Diabetes Mellitus and Atherosclerosis
Stout, R. W. (1992) · Developments in cardiovascular medicine · doi:10.1007/978-94-011-2734-9_4 · Cited by 4
Marcus, A. (2001) · The Endocrinologist · doi:10.1097/00019616-200109000-00005 · Cited by 4
Smit, S. E. (2016) · SUNScholar (Stellenbosch University) · Cited by 4
DIET IN THE TREATMENT OF DIABETES
Wahlqvist, M. L. (1980) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1980.tb76876.x · Cited by 4
Diabetic Dyslipidemia and Risk of Cardiovascular Disease
Viljoen, A., Joshi, S., & Wierzbicki, A. S. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch43 · Cited by 4
Risk Factors for Cardiovascular Disease and the Endothelium
Haller, H. G. (1998) · Medical science symposia series · doi:10.1007/978-94-011-5022-4_36 · Cited by 4
Liu, Y., Liu, Y., Zhang, Y., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-11726-z · Cited by 3
“Such patients are predisposed to comorbid chronic conditions like hypertension and diabetes due to obesity and an unhealthy lifestyle 22–24 , significantly heightening the risk of HF 25,26 .”
Hitchman, L. H., Lathan, R., Ravindhran, B., Sidapra, M., Long, J. W., Cowling, A., Keding, A., Watson, J. M., Iglesias, C., Smith, G., et al. (2025) · International Wound Journal · doi:10.1111/iwj.70740 · Cited by 5
“The lower eligible rate was compensated for by the high concordance with treatment and follow-up [9, 38].”
Liu, Q., Qiu, J., Sun, S.-Y., Wang, X.-Q., Sun, Z.-G., & Zhao, H. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.974294 · Cited by 2
Forkhead box O1 transcription factor; a therapeutic target for diabetic cardiomyopathy
Shafaati, T., & Gopal, K. (2024) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.3389/jpps.2024.13193 · Cited by 3
Beck, L., & Woo, J. G. (2024) · British Journal Of Nutrition · doi:10.1017/s0007114524001521 · Cited by 4
“…in sugar, Na and fat intake while low in fibre, fruits and vegetables contribute to the development of heart disease in adults (2 – 4) and increase the risk for other cardiometabolic diseases that contribute to heart disease, including diabetes (5) , HTN (6) , obesity (7) and dyslipidae-mia (8) .”
BackgroundSteinke, P., Schupp, T., Kuhn, L., Abumayyaleh, M., Ayoub, M., Mashayekhi, K., Bertsch, T., Ayasse, N., Jannesari, M., Siegel, F. P., et al. (2024) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2024.12.001 · Cited by 3
Variations in the Enzyme Activity of Carbohydrate Metabolic Disorder on Cardiac Function
Sreenivasan, R., Moorthy, P. K., Deecaraman, M., et al. (2010) · Cited by 3
Mixture survival trees for cancer risk classification
Jia, B., Zeng, D., Liao, J. J. Z., et al. (2022) · Lifetime Data Analysis · doi:10.1007/s10985-022-09552-w · Cited by 3
“The analysis (Kannel and McGee 1979; Kannel et al. 1979; Wilson et al. 1998) revealed that coronary heart disease risk is associated with age, diabetes, blood pressure, cholesterol level and smoking status.”
BackgroundRasooly, D., Yang, Q., Moonesinghe, R., Khoury, M. J., & Patel, C. J. (2022) · Public Health Genomics · doi:10.1159/000526242 · Cited by 3
Diseases of Renal Microcirculation: Diabetic Nephropathy
Riphagen, I. J., Heerspink, H. J. L., Gans, R. O. B., & Gaillard, S. (2014) · Springer eBooks · doi:10.1007/978-3-642-37393-0_149-1 · Cited by 3
“increase in the risk of cardiovascular disease (Stamler et al. 1993; Kannel and McGee 1979).”
BackgroundSugidachi, A., Ohno, K., Jakubowski, J. A., Ito, Y., Tomizawa, A., & Mizuno, M. (2017) · TH Open · doi:10.1055/s-0037-1605361 · Cited by 3
Awal, A., Tareq, N., Bhattacharjee, B., et al. (2018) · University Heart Journal · doi:10.3329/uhj.v12i2.36386 · Cited by 3
Diabetes and Endothelial Function: Implications for Coronary Angioplasty
Anderson, T. J. (2001) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1321-6_14 · Cited by 3
Insuficiencia cardíaca y diabetes
Thierer, J. M. (2026) · Revista Argentina de Cardiología · doi:10.7775/rac.v74i1.2642 · Cited by 3
“(9) Pero, además, los pacientes con insuficiencia cardíaca, si son diabéticos, tienen peor evolución y en numerosas series la diabetes es en ellos un predictor independiente de mal pronóstico.”
Amputation and the diabetic foot: learning from a case study
Wilson, D. J. (2005) · British Journal of Community Nursing · doi:10.12968/bjcn.2005.10.sup4.20145 · Cited by 3
Diabetes: The Latest Trends in Glycemic Control
Giurini, J. M., Cook, E. A., & Cook, J. J. (2007) · Clinics in Podiatric Medicine and Surgery · doi:10.1016/j.cpm.2006.12.001 · Cited by 3
Diabète sucré et athérosclérose. Physiopathologie de la macroangiopathie diabétique
Leuténegger, M., & Bertin, É. (1995) · La Revue de Médecine Interne · doi:10.1016/0248-8663(96)80662-x · Cited by 3
Large brachial artery diameter and diabetes in post-menopausal women
Montalcini, T., Gorgone, G., Gazzaruso, C., et al. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.02.009 · Cited by 3
Anesthesia Protocol for Heel Pressure Ulcer Debridement
O’Neill, D. K., Tsui, S.-M., Ayello, E. A., et al. (2012) · Advances in Skin & Wound Care · doi:10.1097/01.asw.0000414704.48514.fb · Cited by 3
Zanolla, L., & Vassanelli, C. (2007) · Journal of Cardiovascular Medicine · doi:10.2459/01.jcm.0000278445.04613.27 · Cited by 3
Risk Factors for Cardiovascular Disease and the Framingham Study Equation
Kannel, W. B., & Wilson, P. W. F. (2006) · Fundamental and clinical cardiology · doi:10.3109/9781420019667.001 · Cited by 3
Self-citationZhao, C., Ji, M., Zhang, J., Jia, Q., Liu, J.-Y., An, F., Chen, Z., Li, L., Wang, L., Ma, W., et al. (2018) · Bioscience Reports · doi:10.1042/bsr20181502 · Cited by 3
Rajabi, M. R., Razzaghof, M., & Kashani, H. H. (2019) · Comparative Clinical Pathology · doi:10.1007/s00580-019-03027-5 · Cited by 3
Moradi-Podeh, B., Kheirollah, A., Ahmmadpour, F., et al. (2018) · Journal of Herbmed Pharmacology · doi:10.15171/jhp.2018.16 · Cited by 3
“according to reported by numerous studies (20-22).”
Nilsson, P., Viljoen, A., & Wierzbicki, A. (2010) · doi:10.1002/9781444324808.ch40 · Cited by 1
The Worth of Diabetes Screening Programs
O’Sullivan, J. B., & Kannel, W. B. (1983) · Journal of Public Health Policy · doi:10.2307/3342430 · Cited by 3
Self-citation4 The natural history of non-insulin-dependent diabetes mellitus
Singh, B. M., Rutter, J., & Fitzgerald, M. G. (1988) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(88)80036-3 · Cited by 3
Lipid and nonlipid benefits of statins.
CHILTON, R. J. (2003) · PubMed · Cited by 3
Berton, A. D., & Odom, K. B. (1980) · Springer eBooks · doi:10.1007/978-1-4684-8863-0 · Cited by 3
Prevention of cardiovascular disease
Barbir, M., Lazem, F., & Ilsley, C. D. J. (1996) · Developments in cardiovascular medicine · doi:10.1007/978-94-011-5406-2_35 · Cited by 3
Klaff, L. J., & Palmer, J. P. (1986) · Cardiology Clinics · doi:10.1016/s0733-8651(18)30636-2 · Cited by 3
Watanabe, N., Takaku, T., Iriyama, N., Iwanaga, E., Kimura, Y., Ishikawa, M., Nakayama, H., Sato, E., Tabayashi, T., Mitsumori, T., et al. (2025) · Cardio-Oncology · doi:10.1186/s40959-025-00366-x · Cited by 2
“Among the risk factors, age, CKD, and diabetes were well-known risk factors for VAEs [11–14]; however, statistical significance was demonstrated only in univariate analysis.”
Sultana, R., Anisuzzaman, S. M., Begum, A. A., et al. (1970) · International Current Pharmaceutical Journal · doi:10.3329/icpj.v1i4.10060 · Cited by 2
“From several studies it is obvious that diabetes is associated with a marked increase in the risk of ischemic heart disease (Kannel and McGee, 1979).”
BackgroundSingaram, V., & Pratley, R. E. (2007) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2007.047 · Cited by 2
“In the Framingham Heart Study, DM was associated with a 2- to 4fold higher risk of coronary heart disease and stroke while the risk of congestive heart failure (CHF) among those with DM was 6- to 10-fold higher than among those without.(4) In the recent Heart Protection Study, patients with DM and a history of cardiov…”
BackgroundGlucose and insulin management in the post-MI setting
McNulty, P. H. (2002) · Current Diabetes Reports · doi:10.1007/s11892-002-0055-9 · Cited by 2
Espíndola-Fernández, D. A., Ocampo, D. A., Gallo‐Villegas, J., et al. (2017) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2017.01.006 · Cited by 2
Rustom, A., Rahman, M. M., Iqbal, S. A., et al. (2020) · Journal of Armed Forces Medical College Bangladesh · doi:10.3329/jafmc.v14i2.45906 · Cited by 2
Glycaemic Control and Protection of the Vasculature from Glucose Toxicity
Ding, H., & Chris, R. B. (2011) · InTech eBooks · doi:10.5772/24862 · Cited by 2
Use of cardiovascular disease medications and mortality in people with older onset diabetes.
Klein, R., Moss, S. E., & Klein, R. (1992) · American Journal of Public Health · doi:10.2105/ajph.82.8.1142 · Cited by 2
Cost of diabetes-related complications: current issues, future directions
Summers, K. H., & Songer, T. J. (2003) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.3.1.17 · Cited by 2
Diabetes and Atherosclerosis: Mechanisms and Management
Horvit, P. K., & Garber, A. J. (1998) · Endocrine Practice · doi:10.4158/ep.4.2.112 · Cited by 2
DIABETIC FOOT- VASCULOPATHY ASSESSMENT AND ANALYSIS OF RISK FACTORS OF AMPUTATION
Pandurengan, K. (2015) · International Journal of Research in Medical Sciences · doi:10.5455/2320-6012.ijrms20150113 · Cited by 2
Zamorano, J. L., Padial, L. R., Cosín, J., Martínez, A. H., Gutiérrez‐Chico, J. L., de Isla, L. P., Arístegui, R., & Masramon, X. (2008) · Journal of International Medical Research · doi:10.1177/147323000803600630 · Cited by 2
Χούσος, Η., Perrea, D. N., Kyriaki, D., et al. (2010) · Diabetes and Vascular Disease Research · doi:10.1177/1479164110369687 · Cited by 2
Vitamin D as an accelerator of atherosclerotic calcification: a D-tail that may be a Trojan horse
Hellemons, M. E., & Bakker, S. J. L. (2010) · Diabetologia · doi:10.1007/s00125-010-1928-0 · Cited by 2
“Such changes could easily occur in response to vitamin D supplementation, increasing the already greater known risk of atherosclerotic vascular events in patients with diabetes and in persons at increased risk of developing diabetes [4, 5].”
BackgroundPlatelet aggregation in diabetic Nigerians
Bakari, A. G., Onyemelukwe, G., & Mba, E. C. (2019) · International Journal of Diabetes and Metabolism · doi:10.1159/000497590 · Cited by 2
Lipoprotein (LDL and HDL) Oxidation in Diabetes Mellitus
Kaplan, M., Aviram, M., & Hayek, T. (2013) · Contemporary diabetes · doi:10.1007/978-1-4614-7554-5_9 · Cited by 2
Cardiovascular Disease in Women
Meagher, E. A. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-533-6_16 · Cited by 2
Krishnegowda, C., & Swamy, M. (2016) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20161932 · Cited by 2
Losito, A., Pittavini, L., Zampi, I., & Zampi, E. (2016) · International Journal of Nephrology · doi:10.1155/2016/7180784 · Cited by 2
“The higher prevalence of CVD in diabetes than in the general population was shown many years ago in the Framingham study and has been regularly confirmed by many studies [2, 3].”
ResultAtmaca, A. A., Doğan, S., Dağdelen, S., Kabakçı, G., Kes, S., Nazlı, N., & Erbas, T. A. (2006) · PubMed Central · Cited by 2
Ravichandran, Meena, R. K., Sharma, S., et al. (2018) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.2478/rjdnmd-2018-0018 · Cited by 2
“The diastolic abnormalities may present in diabetics without diabetic complications of cardiovascular system [8].”
Diabetes mellitus as a risk factor for ischemic stroke: a case control study
Singh, S. K., Semwal, J., Shikha, D., et al. (2019) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20191383 · Cited by 2
Metadata
- Authors
- Kannel, W. B., & McGee, D. L.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 1979-03-01
- Volume
- 2
- Issue
- 2
- Pages
- 120-126
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2059537042
- Cited by
- 1,203
- References
- 0
- Citations by year
- 2026: 11 · 2025: 15 · 2024: 17 · 2023: 19 · 2022: 19 · 2021: 40 · 2020: 31 · 2019: 39 · 2018: 41 · 2017: 38 · 2016: 43 · 2015: 55 · 2014: 50 · 2013: 35 · 2012: 36
- FWCI
- 4.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetes mellitus, impaired glucose tolerance, cardiovascular risk, coronary artery disease, peripheral vascular disease, stroke, cardiovascular mortality, heart failure, sex differences, cardiovascular risk factors, Framingham cohort
- MeSH terms
- Age Factors, Aged, Cardiovascular Diseases, Female, Glucose Tolerance Test, Humans, Male, Massachusetts, Middle Aged, Prospective Studies, Risk, Sex Factors, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
